Cuba MJ, Jordán PY, Navarro ARE, Batista SL, González PI

Language: Spanish
References: 15
Page: 124-129
PDF size: 142.42 Kb.

ABSTRACT

Many of the malformations or abnormalities of anatomical or functional character provoked in the fetus are due to drug use by the mother during gestation. These disorders can be detected during intrauterine life, immediately after birth or at times, many years later, but they are generally diagnosed early and in certain circumstances they can compromise the life of the newborn. The main teratogenic effects of some drugs that can predispose to heart diseases and other congenital abnormalities are set out in this article in a general way. The environment of a pregnant woman is loaded with aggressive substances for the future product of gestation. The majority of the most relevant malformations are produced during the teratogenic period, which comprises weeks third to eigth of gestation. Secondary prevention measures are based on prenatal diagnosis and genetic counseling.

REFERENCES

1. Hamilton WJ, Mossman HW. Embriología Humana, desarrollo prenatal de la forma y la función. 4ta ed. Buenos Aires: Inter-Médica; 1973. p. 204-17.

2. Langman J, Sadler TW. Embriología Medica con orientación clínica. 8va ed.. Argentina: Médica Pa-namericana; 2004. p. 116-22.

3. Dovales C. Rossel W, Álvarez I. Morfofisiología Humana I. La Habana: Ecimed; 2002.

4. López Castellano A, Moreno Royo L, Villagrasa SV. Manual de Farmacología. España: Elsevier; 2005. p. 114-7.

5. Achong Ley M, Cuesta Campos ER, Fernández de Landax M, Guía Gómez M, Levi Rodríguez M, Mo-rón Rodríguez FJ, et al. Manual de Farmacología. La Habana: Minsap; 1988.

6. van Gelder MM, van Rooij IA, Miller RK, Zielhuis GA, de Jong-van den Berg LT, Roeleveld N. Tera-togenic mechanisms of medical drugs. Hum Reprod Update. 2010;16(4):378-94.

7. Alonso RM, Cejas A, Rodríguez A, Serrat I. Posibles efectos teratogénicos de la medicación materna so-bre el feto. Rev Cubana Med Gen Integr. 1987; 3(3):21-6.

8. García JC, Vergel G, Zapata A. Embarazo y medi-camentos en un área de salud. Rev Cubana Med Gen Integr [Internet]. 1999 [citado 13 Feb 2012]; 5(3):[aprox. 3 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21251999000300001&lng=es.

9. Cruz M, Bosch J. Aspectos básicos. En: Atlas de síndromes pediátricos. 1ra. ed. Barcelona: Espaxs; 1998. p.15-30.

10. Emery AE, Mueller RF. Principios de genética mé-dica. 6ta. ed. Madrid: Churchill Livingstone; 1992.

11. Medline Plus. Desarrollo fetal [Internet]. USA: U.S. National Library of Medicine; 2001 [citado 10 Ene 2012]. Disponible en: http://www.pcs.adam.com/ency/article/002398.htm

12. Mueller RF, Young ID. Genética y anomalías congénitas. En: Emery´s genética médica. 10ma. ed. Madrid: Marbán Libros; 2001. p. 223-34.

13. Dyce E, Chikuy M. Registro, incidencia y diagnós-tico prenatal de las malformaciones congénitas mayores más severas. Rev Cubana Med Gen Integr. 1999;15(4):403-8.

14. Elhatton P. Farmacodivulgación. Rev Cubana Farm [Internet]. 2003 [citado 5 Ene 2012];37(2):[aprox. 4 p.]. Disponible en: http://bvs.sld.cu/revistas/far/vol37_2_03/far10203.htm

15. Perinatology.com. Drugs in pregnancy and breast-feeding [Internet]. 2009 [citado 5 Ene 2012]. Dispo-nible en: http://www.perinatology.com/exposures/druglist.htm